Chandan Healthcare Limited (NSE:CHANDAN)
India · Delayed Price · Currency is INR 239.10
+1.00 (0.42%)
At close: Jul 31, 2026
Chandan Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 270.57 | 221.71 | 162.77 | 33.68 | -11.09 |
Depreciation & Amortization | 97.8 | 67.45 | 34.04 | 20.9 | 19.61 |
Provision & Write-off of Bad Debts | 0.53 | -10.94 | 0.88 | 0.39 | 52.08 |
Other Operating Activities | 49.35 | 61.42 | 28.41 | 37.94 | 22.63 |
Change in Accounts Receivable | -391.96 | -169.94 | -29.6 | 49.71 | -103.74 |
Change in Inventory | -23.76 | -133.94 | -84.35 | -33.11 | -4.5 |
Change in Accounts Payable | 149.61 | 54.31 | -135.01 | 83.45 | 74.75 |
Change in Other Net Operating Assets | 9.6 | -380.6 | 34.04 | -147.98 | 11.27 |
Operating Cash Flow | 161.74 | -290.53 | 11.17 | 44.98 | 61 |
Operating Cash Flow Growth | - | - | -75.16% | -26.26% | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -425.55 | -387.05 | -195.42 | -52.79 | -66.42 |
Investment in Securities | -13.35 | 22.3 | 37.1 | -12.88 | -42.36 |
Other Investing Activities | 39.94 | 7.3 | 10.05 | 0.78 | 1.3 |
Investing Cash Flow | -398.96 | -357.45 | -148.27 | -64.9 | -107.47 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 55.82 | 122.53 | 206.58 | 47.73 | 14.97 |
Net Debt Issued (Repaid) | 55.82 | 122.53 | 206.58 | 47.73 | 14.97 |
Issuance of Common Stock | 213.35 | 622.71 | - | - | 47.4 |
Common Dividends Paid | - | -30 | -24.85 | - | -11.5 |
Other Financing Activities | -58.2 | -44.18 | -26.07 | -23.13 | -16.09 |
Financing Cash Flow | 210.97 | 671.06 | 155.66 | 24.6 | 34.78 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | -26.25 | 23.07 | 18.56 | 4.68 | -11.7 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -263.81 | -677.58 | -184.25 | -7.82 | -5.42 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -9.40% | -29.29% | -10.43% | -0.57% | -0.45% |
Free Cash Flow Per Share | -10.49 | -32.94 | -9.21 | -0.39 | -0.27 |
Levered Free Cash Flow | -461.54 | -475 | -197.5 | 10.69 | -35.9 |
Unlevered Free Cash Flow | -424.77 | -449.67 | -181.99 | 21.95 | -25.91 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 58.2 | 44.18 | 26.07 | 23.13 | 16.09 |
Cash Income Tax Paid | 97.13 | 85.49 | 49.05 | 11.13 | 1.18 |
Change in Working Capital | -256.5 | -630.17 | -214.92 | -47.93 | -22.23 |